NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded HTG Molecular Diagnostics a $1.01 million award to continue development of targeted sequencing products, the Tucson, Ariz.-based company said today.

The one-year Phase II Small Business Innovation Research grant allows HTG to continue work that was carried out under a $599,000 Phase I SBIR grant to the company for the Nuclease Robe Mediated Sequencing Project (HTG EdgeSeq), which seeks to develop targeted sequencing products using HTG's core RNA analysis technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.